Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease

Ricardo G. Orsini; Rob H. A. Verhoeven; Valery E. P. P. Lemmens; Liza N. van Steenbergen; Ignace H. J. T. de Hingh; Grard A. P. Nieuwenhuijzen; Harm J. T. Rutten

doi:10.1016/j.ejca.2015.06.005

Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease

Ricardo G. Orsini, Rob H. A. Verhoeven, Valery E. P. P. Lemmens, Liza N. van Steenbergen, Ignace H. J. T. de Hingh, Grard A. P. Nieuwenhuijzen, Harm J. T. Rutten^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background: Young patients with rectal cancer tend to present with more advanced-stage disease and unfavourable tumour morphology. The effects of these tumour characteristics on survival in this particular patient group are unclear. Methods: Population-based data from the Netherlands Cancer Registry (NCR) were used. Data from patients diagnosed with rectal cancer between 1989 and 2010 were selected. Younger patients (

Original language	English
Pages (from-to)	1675-1682
Journal	European Journal of Cancer
Volume	51
Issue number	13
DOIs	https://doi.org/10.1016/j.ejca.2015.06.005
Publication status	Published - Sept 2015

Keywords

Rectal cancer
Young patients
Morphology
Survival
Stage
Treatment
Adjuvant chemotherapy

Access to Document

10.1016/j.ejca.2015.06.005

Cite this

@article{30659e87c3f448959da0ce3850c976d2,

title = "Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease",

abstract = "Background: Young patients with rectal cancer tend to present with more advanced-stage disease and unfavourable tumour morphology. The effects of these tumour characteristics on survival in this particular patient group are unclear. Methods: Population-based data from the Netherlands Cancer Registry (NCR) were used. Data from patients diagnosed with rectal cancer between 1989 and 2010 were selected. Younger patients (",

keywords = "Rectal cancer, Young patients, Morphology, Survival, Stage, Treatment, Adjuvant chemotherapy",

author = "Orsini, {Ricardo G.} and Verhoeven, {Rob H. A.} and Lemmens, {Valery E. P. P.} and {van Steenbergen}, {Liza N.} and {de Hingh}, {Ignace H. J. T.} and Nieuwenhuijzen, {Grard A. P.} and Rutten, {Harm J. T.}",

year = "2015",

month = sep,

doi = "10.1016/j.ejca.2015.06.005",

language = "English",

volume = "51",

pages = "1675--1682",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

number = "13",

}

TY - JOUR

T1 - Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease

AU - Orsini, Ricardo G.

AU - Verhoeven, Rob H. A.

AU - Lemmens, Valery E. P. P.

AU - van Steenbergen, Liza N.

AU - de Hingh, Ignace H. J. T.

AU - Nieuwenhuijzen, Grard A. P.

AU - Rutten, Harm J. T.

PY - 2015/9

Y1 - 2015/9

N2 - Background: Young patients with rectal cancer tend to present with more advanced-stage disease and unfavourable tumour morphology. The effects of these tumour characteristics on survival in this particular patient group are unclear. Methods: Population-based data from the Netherlands Cancer Registry (NCR) were used. Data from patients diagnosed with rectal cancer between 1989 and 2010 were selected. Younger patients (

AB - Background: Young patients with rectal cancer tend to present with more advanced-stage disease and unfavourable tumour morphology. The effects of these tumour characteristics on survival in this particular patient group are unclear. Methods: Population-based data from the Netherlands Cancer Registry (NCR) were used. Data from patients diagnosed with rectal cancer between 1989 and 2010 were selected. Younger patients (

KW - Rectal cancer

KW - Young patients

KW - Morphology

KW - Survival

KW - Stage

KW - Treatment

KW - Adjuvant chemotherapy

U2 - 10.1016/j.ejca.2015.06.005

DO - 10.1016/j.ejca.2015.06.005

M3 - Article

C2 - 26159248

SN - 0959-8049

VL - 51

SP - 1675

EP - 1682

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 13

ER -